4//SEC Filing
Astle Christopher 4
Accession 0000899243-22-010796
CIK 0001403752other
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 9:00 PM ET
Size
5.5 KB
Accession
0000899243-22-010796
Insider Transaction Report
Form 4
Zymeworks Inc.ZYME
Astle Christopher
SVP & Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-10+125,000→ 125,000 totalExercise: $7.00Exp: 2032-03-09→ Common Shares (125,000 underlying)
Footnotes (1)
- [F1]Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.
Documents
Issuer
Zymeworks Inc.
CIK 0001403752
Entity typeother
Related Parties
1- filerCIK 0001915257
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 7:00 PM ET
- Accepted
- Mar 11, 9:00 PM ET
- Size
- 5.5 KB